Loading…
bioAffinity Technologies, Inc. is projected to decline to $0.5576 by 2027, a -7% move from its current price of $0.5974. BIAF is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.5682 | $0.5971 | $0.6273 | -0.06% |
| Aug 6 | $0.5564 | $0.5967 | $0.6399 | -0.12% |
| Aug 7 | $0.5474 | $0.5964 | $0.6497 | -0.18% |
| Aug 8 | $0.5399 | $0.596 | $0.658 | -0.23% |
| Aug 9 | $0.5333 | $0.5957 | $0.6653 | -0.29% |
| Aug 10 | $0.5274 | $0.5953 | $0.672 | -0.35% |
| Aug 11 | $0.522 | $0.595 | $0.6781 | -0.41% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.522 | $0.595 | $0.6781 | -0.41% |
| Week 2 | $0.4924 | $0.5925 | $0.713 | -0.81% |
| Week 3 | $0.4704 | $0.5901 | $0.7402 | -1.22% |
| Week 4 | $0.4524 | $0.5877 | $0.7635 | -1.62% |
| Week 5 | $0.4368 | $0.5853 | $0.7842 | -2.02% |
| Week 6 | $0.4231 | $0.5829 | $0.8032 | -2.42% |
| Week 7 | $0.4107 | $0.5805 | $0.8207 | -2.82% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
bioAffinity Technologies, Inc. is a healthcare company that develops non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates through two segments: Diagnostic Research and Development; and Laboratory Services.
It offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.
bioAffinity Technologies, Inc. (BIAF) is the asset with a current price of $0.6444. It is listed with a market capitalization of $4.05M and ranks 5048 in market size. The 2026 forecast shows an average price of $0.6444 with a low of $0.585 and a high of $0.7511, and a forecast ROI of 0 with a NEUTRAL sentiment.
A major floor 29.4% below — a decisive break under it would weaken the trend.
Price is testing support right now (2.1% away) — a key level to hold.
The nearest ceiling, 42.5% above — a clean break opens room to run.
A major ceiling 693.4% above — clearing it would confirm fresh momentum.
Key BIAF support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BIAF market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.6332 | Sell | $0.6358 | Sell |
| MA 10 | $0.6606 | Sell | $0.659 | Sell |
| MA 20 | $0.7062 | Sell | $0.7319 | Sell |
| MA 50 | $1.07 | Sell | $1.07 | Sell |
| MA 100 | $1.90 | Sell | $1.52 | Sell |
| MA 200 | $1.72 | Sell | $3.40 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 30.57 | Neutral |
| Stoch RSI (14) | 87.71 | Sell |
| CCI (20) | -113.19 | Sell |
| Williams %R (14) | -69.34 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | -13.16 | Sell |
| Bollinger %B (20,2) | 0.18 | Neutral |
| Stochastic %K (14) | 30.66 | Neutral |
| TRIX (15) | -2.17 | Sell |
| Awesome (5,34) | -0.16 | Sell |
| Ultimate (7,14,28) | 34.83 | Neutral |
| Momentum (10) | -0.08 | Sell |
| Aroon Osc (25) | -76.00 | Sell |
| Hull MA (9) | 0.60 | Sell |
| ADX (14) | 44.28 | Sell |
| ATR (14) | 0.04 | Info |
The 30-day technical picture is NEUTRAL. The RSI(14) stands at 30, indicating subdued momentum. The short- to mid-term moving averages are $1.09 for the SMA50 and $1.73 for the SMA200, signaling potential resistance versus recent price levels.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.585 | $0.5974 | $0.6917 | 0% | Neutral | |
| $0.4121 | $0.5576 | $0.8137 | -7% | Neutral | |
| $0.3707 | $0.5305 | $0.823 | -11% | Neutral | |
| $0.2771 | $0.4158 | $0.6758 | -30% | Bearish | |
| $0.3386 | $0.5303 | $0.8958 | -11% | Neutral | |
| $0.4001 | $0.6521 | $1.14 | +9% | Neutral | |
| $0.4083 | $0.6911 | $1.24 | +16% | Neutral | |
| $0.4218 | $0.7402 | $1.37 | +24% | Bullish | |
| $0.3398 | $0.6175 | $1.17 | +3% | Neutral | |
| $0.3226 | $0.6067 | $1.17 | +2% | Neutral | |
| $0.4231 | $0.9373 | $1.98 | +57% | Bullish | |
| $0.507 | $1.13 | $2.59 | +89% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.585 | $0.5974 | $0.6896 | +0.00% |
| September 2026 | $0.4606 | $0.5575 | $0.7025 | -6.69% |
| October 2026 | $0.462 | $0.5664 | $0.7274 | +1.61% |
| November 2026 | $0.4346 | $0.5385 | $0.702 | -4.93% |
| December 2026 | $0.4185 | $0.5235 | $0.6917 | -2.78% |
Click any year to see its month-by-month BIAF forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
bioAffinity Technologies, Inc.'s 2026 outlook centres on $0.5974, within a $0.585 to $0.6917 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, BIAF could reach as high as $0.8137, with a base case around $0.5576 and support toward $0.4121 — roughly -7% from $0.5974. Price action looks broadly range-bound.
Expect BIAF to range from $0.3707 to $0.823 through 2028. The $0.5305 average target implies a -11% move from current prices. That is -5% versus the projected 2027 average. A consolidation phase looks the most probable path here.
The BIAF price prediction for 2029 points to an average of $0.4158 (low $0.2771, high $0.6758) — a potential decline of -30% on today's $0.5974. A cyclical pullback looks likely — prices rarely move in a straight line.
In 2030, BIAF is projected to trade between $0.3386 and $0.8958, averaging $0.5303 — a potential decline of -11% from today's $0.5974. That is up +28% on the projected 2029 average. A consolidation phase looks the most probable path here.
bioAffinity Technologies, Inc.'s 2031 outlook centres on $0.6521, within a $0.4001 to $1.14 range. That is up +23% on the projected 2030 average. That marks a +9% change versus current levels. Price action looks broadly range-bound.
By 2032, BIAF could reach as high as $1.24, with a base case around $0.6911 and support toward $0.4083 — roughly +16% from $0.5974. A consolidation phase looks the most probable path here.
Expect BIAF to range from $0.4218 to $1.37 through 2033. The $0.7402 average target implies a +24% move from current prices. That is up +7% on the projected 2032 average. Momentum favours further upside here.
The BIAF price prediction for 2034 points to an average of $0.6175 (low $0.3398, high $1.17) — a potential gain of +3% on today's $0.5974. A consolidation phase looks the most probable path here.
In 2035, BIAF is projected to trade between $0.3226 and $1.17, averaging $0.6067 — a potential gain of +2% from today's $0.5974. That is -2% versus the projected 2034 average. Price action looks broadly range-bound.
bioAffinity Technologies, Inc.'s 2040 outlook centres on $0.9373, within a $0.4231 to $1.98 range. That is up +54% on the projected 2035 average. That marks a +57% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, BIAF could reach as high as $2.59, with a base case around $1.13 and support toward $0.507 — roughly +89% from $0.5974. Momentum favours further upside here.
Investing $1,000 in BIAF today (≈ 1,673.920321 BIAF) could be worth
$1,885.89
+$885.89 (+89%) by 2050 · US Dollar
Based on the average projected BIAF price of $1.13 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BIAFwould be worth at today's price.
$1,000 invested in BIAF on Jul 31, 2025 (≈ 105.152469 BIAF) would be worth
$62.82
-$937.18 (-93.7%) today · 0.06× · US Dollar
Based on a BIAF entry price of $9.51 vs. today's $0.5974.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.66 | $905.15 | -9.5% |
| 1 month ago | $0.844 | $707.82 | -29.2% |
| 3 months ago | $2.19 | $272.79 | -72.7% |
| 6 months ago | $1.27 | $470.39 | -53.0% |
| 1 year ago | $9.51 | $62.82 | -93.7% |
| All time (3.9y) ago | $249 | $2.4 | -99.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BIAF forecast.
$1.20 is within our bullish range by 2032, but above the base case.
Implied market cap at $1.20: $7.54M
The multi-year forecast shows a varied path. The 2029 forecast is Bearish with min $0.2923, avg $0.4429, max $0.7264 and ROI -31.3. The 2030 forecast lowers to an average of $0.5722 with min $0.3612, max $0.9759 and ROI -11.2.
The 2031 forecast improves to avg $0.7015, max $1.24, min $0.4249 with ROI 8.9, followed by 2032 at avg $0.7458, max $1.36, min $0.4343 and ROI 15.7. The 2033 forecast shows stronger upside with avg $0.7989, max $1.49, min $0.448 and ROI 24. The path includes modest gains in 2034 (avg $0.6571, max $1.26, min $0.3552, ROI 2) and 2035 (avg $0.6521, max $1.28, min $0.3401, ROI 1.2).
The longer-horizon years show clearer upside, with 2040 avg $0.9976, max $2.14, min $0.4489 and ROI 54.8, and 2050 avg $1.21, max $2.79, min $0.5467 and ROI 88.5, both with a BULLISH sentiment.
Tap a question to reveal the answer.
For 2030, the forecast shows min $0.3612, avg $0.5722, max $0.9759 with ROI -11.2 and sentiment NEUTRAL.
Forecasts show a Bearish year in 2029 (ROI -31.3) followed by years of recovery (2031 ROI 8.9, 2032 ROI 15.7, 2033 ROI 24) and bullish years in 2040 (ROI 54.8) and 2050 (ROI 88.5). These are estimates and not guarantees.
Yes. The 2040 forecast max is $2.14 and the 2050 forecast max is $2.79, indicating a potential to exceed $2 in those years.
Current price: $0.6444 and Market cap: $4.05M.
For 2033, the average price is $0.7989 with a min of $0.448 and a max of $1.49, and ROI of 24, with sentiment NEUTRAL.
bioAffinity Technologies, Inc. Community Discussion
0Share your bioAffinity Technologies, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.